Consumer Health Neurology

Energenesis Completes Phase I Trial of ENERGI-F705PD, a Novel Oral Therapy for Parkinson’s Disease

The Phase I trial of ENERGI-F705PD tablet was a randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, and pha...

 August 04, 2025 | News

Quanterix Launches First-to-Market p‑Tau 205 and 212 Assays, Expanding Alzheimer’s Biomarker Portfolio

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, announced the first to market, com...

 August 01, 2025 | News

Alamar Biosciences and Germany’s DZNE Join Forces to Advance Early Detection of Neurodegenerative Diseases

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced a strategic collaboration with the Germa...

 July 31, 2025 | News

Alamar Biosciences and DZNE Join Forces to Advance Neurodegeneration Research with Ultra-Sensitive Proteomics

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease,announced a strategic collaboration with the German...

 July 30, 2025 | News

Fujitsu and Acer Medical to Launch AI-Powered Gait Analysis for Early Dementia and Parkinson’s Detection in Taiwan

Fujitsu Limited and Acer Medical Inc., a provider of AI-powered medical imaging and preventative medicine, today announced a collaborative agreement to dev...

 July 16, 2025 | News

Leica Microsystems Unveils ARveo 8x Hybrid Surgical Microscope for Enhanced Precision in Neurosurgery and Spine Procedures

 Leica Microsystems, a Danaher company and a leading provider of microscopy and scientific instrumentation, has launched ARveo 8x, a hybrid surgical m...

 July 01, 2025 | News

Klotho Neurosciences Advances KLTO-202 Gene Therapy Manufacturing for ALS Clinical Trials

Klotho Neurosciences, Inc. announced that it is moving forward with manufacturing and process development work in preparation for clinical trials of K...

 July 01, 2025 | News

SineuGene Therapeutics Receives FDA Orphan Drug Designation for Gene Therapy SNUG01 in ALS

SineuGene Therapeutics, a clinical-stage biotechnology company focused on gene therapies for neurological diseases, announced that the U.S. Food and Drug A...

 June 27, 2025 | News

Quanterix Expands Global Reach with South Korea Approval for HD-X Simoa Immunoassay Analyzer

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that the HD-X ...

 June 26, 2025 | News

XtalPi and DoveTree Sign $100M+ LOI to Accelerate AI-Driven Drug Discovery Across Oncology and Neurology

 XtalPi, a global leader in AI- and robotics-powered drug and materials discovery,  announced it has signed a Letter of Intent (LOI) with DoveTre...

 June 23, 2025 | News

Alamar Biosciences, Gates Ventures, and Alzheimer's Disease Data Initiative Launch Global Effort to Build Largest Plasma Proteome Atlas for Alzheimer’s

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, the Alzheimer's Disease Data Initiative and Gates ...

 June 11, 2025 | News

XellSmart Advances Global Leadership in iPSC-Derived Cell Therapies for CNS Disorders

XellSmart Biomedical Co., Ltd. (Suzhou/Shanghai, China) is a leading biotechnology company dedicated to the development of innovative iPSC-derived cell the...

 June 03, 2025 | News

CorestemChemon's Neuronata-R® Shows Promising Efficacy in Early-Stage ALS, Sets Sights on Accelerated FDA Approval

Neuronata-R®, an autologous bone marrow-derived mesenchymal stem cell (MSC) therapy for amyotrophic lateral sclerosis (ALS), has demonstrated meaningfu...

 May 30, 2025 | News

UniXell Biotech Initiates China’s First iPSC-Based Cell Therapy Trial for Parkinson’s Disease

Shanghai UniXell Biotechnology Co., Ltd. (UniXell Biotech), a biotech company dedicated to innovative cell therapies, announced the successful first admini...

 May 26, 2025 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close